NCT00162071View on ClinicalTrials.gov

A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2006

Conditions
Cardiovascular DiseaseIschemic Heart Disease
Interventions
DRUG

apadenoson

Trial Locations (1)

10025

Local Institution, New York

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY